EGFR targeting enhances the efficiency of chemotherapy through inhibiting IRE1α-XBP1s pathway in colorectal cancer cells

Targeting EGFR combined with chemotherapy is one of the most valuable therapeutic strategies in colorectal cancer. However, resistance remains a major obstacle to improve efficacy. IRE1α-XBP1s signaling pathway is activated in many malignant tumors, and plays important roles in chemoresistance. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Miaomiao, Zhao, Yahui, Liu, Xianghe, Gao, Yang, Zhang, Die, Chang, Mengjiao, Liu, Mei, Xu, Ningzhi, Zhu, Hongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255363/
https://www.ncbi.nlm.nih.gov/pubmed/32489465
http://dx.doi.org/10.7150/jca.44234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255363/
https://www.ncbi.nlm.nih.gov/pubmed/32489465
http://dx.doi.org/10.7150/jca.44234

Ejemplares similares